Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2016 October;68(5) > Minerva Ginecologica 2016 October;68(5):620-1

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

LETTERS TO THE EDITOR  


Minerva Ginecologica 2016 October;68(5):620-1

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Nonavalent HPV vaccine (HPV-9): analysis of pre-registration data

Luciano MARIANI 1, Paolo CRISTOFORONI 2, Antonio PERINO 3, Carlo M. STIGLIANO 4, Mario PRETI 5

1 HPV Unit, Department of Gynecologic Oncology, Regina Elena National Cancer Institute, Rome, Italy; 2 Villa Montallegro Private Hospital, Genoa, Italy; 3 Department of Obstetrics and Gynecology, V. Cervello Hospital, Villa Sofia Hospitals, University of Palermo, Palermo, Italy; 4 Preventive Gynecology Unit, Local Health Service, Cosenza, Italy; 5 Department of Obstetrics and Gynecology, University of Turin, Turin, Italy


PDF  


top of page

Publication History

Cite this article as

Mariani L, Cristoforoni P, Perino A, Stigliano CM, Preti M. Nonavalent HPV vaccine (HPV-9): analysis of pre-registration data. Minerva Ginecol 2016 October;68(5):620-1. 

Corresponding author e-mail

luciorm@libero.it